Skip to main content

Plenary Group

Each full member company of EPAG is represented on the Plenary Group. Meetings are held quarterly and cover the administrative aspects of EPAG such as fiscal updates, current membership statuses, previous meeting actions and future strategic plans. It is also an opportunity for the sub-team leaders to update the Plenary Group on their activities and bring proposals or requests for funding that require Plenary Group approval.

One important aspect of being a Plenary Group participant is ensuring that the member company supports EPAG objectives where possible. This can mean soliciting company input for regulatory guidance feedback, providing in-kind lab resources for the sub-team activities or hosting EPAG meetings at their offices.

The Plenary Group meetings are organized by the EPAG Chairperson, which is a rotating 2-year term filled by a Plenary Group member. Other important roles associated with the Plenary Group are Secretary, Treasurer, Regulatory Feedback Coordinator and Website Lead.

Members

Antti Toppari

Orion

Beatrix Fyrnys

Astrazeneca

Behruz Eslami

Lupin

Christoph Kreher

Boehringer

Clare Butler

Teva

Eunice Costa

Hovione

Gerallt Williams

Aptar

Hlack Mohammed

GSK

Jan Olof Svensson

Astrazeneca

Jason Suggett

Trudell

Jim Lister

Kindeva

Joe Takher-Smith

Viatris (Leader)

Karen Western

Vectura

Martin Schlun

Pari

Michael Malaun

Sandoz

Oksana Olkhovyk

Philips

PJ Scollard

Teva

Richard Poole

Vectura

Sara Poole

Chiesi

Tol Purewal

Secretary

Project Title

  • Objective:
    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras sit amet mauris nec diam vestibulum tristique ut a augue. Vivamus nisl ante, ornare vitae aliquam faucibus, vulputate id urna.
  • Status:
    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras sit amet mauris nec diam vestibulum tristique ut a augue. Vivamus nisl ante, ornare vitae aliquam faucibus, vulputate id urna.

EPAG Meetings

September 29th 2023

The meeting of the EPAG plenary group was held via remote link up on 29th September 2023. Review of actions from the previous meeting was followed by updates on the progress of work by the EPAG sub-teams. The Impactor sub-team, the Nasal sub-team, and the Dissolution sub-team progressed the work in line with their respective work plans.  The Inhalation Magazine published the paper in the August issue summarising the history and achievements by EPAG. The financial status and the Website updates were reviewed. The meeting ended with outline plans for the December 2023 plenary meetings confirming the chairperson.

July 23rd 2023

The meeting of the EPAG plenary group was held via remote link up on 5th July 2023. Review of actions from the previous meeting was followed by updates on the progress of work by the EPAG sub-teams. The Impactor sub-team, the Nasal sub-team, and the Dissolution sub-team, all presented the work progress in line with the plans. A publication for the Inhalation Magazine is in progress summarising the history and achievements of EPAG. The financial status and the Website updates were reviewed. The meeting ended with outline plans for the September and December 2023 plenary meetings confirming the chairperson for each.

March 22nd 2023

The meeting of the EPAG plenary was held via remote link up on 22nd March 2023. 

This meeting was attended by invited members of IPAC-RS, (Chairperson – Mike Needham, Vice-chair – Jen Wylie, and Secretary – Svetlana Lyapustina).

Review of actions from the previous meeting was followed by two invited presentations. One by IPAC-RS entitled “An Introductions to IPAC-RS” and the second entitled “Digital Inhalers Case Study & Lessons from Aircraft Crashes” by Mark-Milton Edwards, Teva. A detailed update on the progress of the work by the EPAG sub-teams followed. Impactor sub-team, the Nasal sub-team, and the Dissolution sub-team, all presented the work progress in line with the plans. A publication for the Inhalation Magazine is in progress summarising the history and achievements of EPAG. The financial status and the Website updates were reviewed. The meeting ended with outline plans for the future plenary meetings over 2023.

December 6th & 7th 2022

The meeting of the EPAG plenary group was held face-to-face via remote link up on the 6th and 7th of December 2022, at Edinburgh, UK.

Review of actions from the previous meeting was followed by an invited lecture presented by Tim Noakes, Koura Global. Updates on the progress of work by the EPAG sub-teams were presented and discussed including plans for the future work by each of the teams. The 5 year plan was reviewed and updated to include the topics of interest to EPAG as well as future planned work by the sub-teams. The sub-teams continue to make good progress.  A number of publications have resulted from the work that will be added to the EPAG website. A paper for publication in the Inhalation Magazine is in progress summarising the history and achievements of EPAG. A number of poster presentations at the DDL conference, December 2022, based on the work by the sub-teams were progressed. The financial status and the Website updates were reviewed. An increase in the annual membership fee was approved at the March meeting, which will be implemented from January 2023.

Meetings